Sign in

Trial result ·

Efficacy of L-Arginine, Myoinositol, and Chromium with Letrozole for Ovulation Induction in Polycystic Ovarian Syndrome: A Randomized Comparative Study.

Written based on 1 research study on PubMed, searched on 13 Nov 2026.

What was studied

This study looked at women with PCOS who had trouble getting pregnant. It was a trial where people were put into groups by chance. In total, 240 women took part, with 60 in each group. The groups got letrozole with chromium, L-arginine, or myoinositol. A fourth group was a control group. Before and after the drugs, the team checked hormones, body weight and body hair. They also checked how well the body used insulin and whether eggs were released.

What they found

Rates of egg release differed between groups at 1, 2 and 3 months. Chromium and myoinositol lowered weight and extra body hair. They also made the body use insulin better. Chromium, myoinositol and L-arginine all lowered testosterone levels. The myoinositol group had the highest pregnancy rates at 1 and 2 months.

What it means for patients

The authors say letrozole with chromium or myoinositol helps eggs to be released. They say these mixes also improved insulin use and extra body hair. L-arginine lowered testosterone. But the authors did not name it in their main conclusion.

Why it is not certain yet

The abstract does not say what the control group got. It does not say if the women or doctors knew the groups. The abstract does not report harms for any group. The checks in the abstract cover only 3 months. It does not say how many women went on to have a baby.

Source

Efficacy of L-Arginine, Myoinositol, and Chromium with Letrozole for Ovulation Induction in Polycystic Ovarian Syndrome: A Randomized Comparative Study.

PubMed · PMID 42573014

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Female infertility publications